MATTHEW DAVID NEAL
Medical Practice in Pittsburgh, PA

License number
Pennsylvania MT188691
Category
Medicine
Type
Graduate Medical Trainee
Address
Address
Pittsburgh, PA 15206

Personal information

See more information about MATTHEW DAVID NEAL at radaris.com
Name
Address
Phone
Matthew Neal, age 52
49 Black Matt Rd, Douglassville, PA 19518
(610) 587-4434
Matthew Neal, age 46
715 Valleyview Dr, Coraopolis, PA 15108
(412) 916-2812
Matthew Neal
15 Neal Park Ln #1, Mansfield, PA 16933
(570) 662-7105
Matthew Neal
144 Sumac St, Philadelphia, PA 19128
(267) 738-8295

Professional information

Matthew Neal Photo 1

Project Engineer At Urs Corporation

Position:
Project Engineer at URS Corporation
Location:
Greater Pittsburgh Area
Industry:
Oil & Energy
Work:
URS Corporation since Jul 2005 - Project Engineer Lettlerle and Associates, LLC Oct 2003 - Jul 2005 - Project Engineer Petroclean Nov 2002 - Oct 2003 - Environmental Services Specialist
Education:
Geneva College 2000 - 2002
BS, Chemical Engineering and Chemistry
Bucknell University 1996 - 2000
BA, Chemical Engineering, General Studies


Matthew Neal Photo 2

General Surgeon At Upmc

Position:
General Surgeon at UPMC
Location:
Greater Pittsburgh Area
Industry:
Hospital & Health Care
Work:
UPMC - General Surgeon


Matthew D Neal Photo 3

Dr. Matthew D Neal, Pittsburgh PA - MD (Doctor of Medicine)

Specialties:
General Surgery
Address:
200 Lothrop St, Pittsburgh 15213
(412) 647-3389 (Phone)
DEPARTMENT OF SURGERY
200 Lothrop St SUITE F675, Pittsburgh 15213
(412) 647-3389 (Phone), (412) 647-1999 (Fax)
Languages:
English
Education:
Medical School
University of Pittsburgh / Main Campus
Graduated: 2006


Matthew Neal Photo 4

Novel Tlr4 Inhibitors For The Treatment Of Human Infectious And Inflammatory Disorders

US Patent:
2013028, Oct 24, 2013
Filed:
Mar 22, 2013
Appl. No.:
13/848809
Inventors:
University of Pittsburgh - of the Commonwealth System of Higher Education - , US
Matthew D. Neal - Pittsburgh PA, US
David J. Hackam - Pittsburgh PA, US
International Classification:
A61K 31/7008, A61K 31/7034
US Classification:
514 35, 514 23, 514 53, 514 25, 536 172, 536 187
Abstract:
The present invention relates to methods of treating infectious, inflammatory and post-traumatic disorders by administering various compounds newly discovered to have TLR4 inhibitory activity. In addition to methods of treatment, the present invention further provides for pharmaceutical compositions comprising said compounds, together with a suitable pharmaceutical carrier. Because TLR4 is the most upstream receptor in the pro-inflammatory LPS signaling cascade, treatments of the invention, which inhibit or antagonize TLR4 action, may avoid the pitfalls associated with other cytokine inhibitors that act further down the pathway and accordingly play a less specific (and perhaps non-critical) role.


Matthew Neal Photo 5

Student At Geneva College

Position:
Student at Geneva College
Location:
Greater Pittsburgh Area
Industry:
Higher Education
Work:
Geneva College - Student
Education:
Geneva College 2008 - 2012